24小时热门版块排行榜    

CyRhmU.jpeg
查看: 2910  |  回复: 7

lb1527

金虫 (小有名气)

[求助] 稿件被拒,编辑给了另外推荐杂志,不想投,我应该怎么给之前的编辑回稿件呢~急求~已有6人参与

稿件被拒,编辑给了另外的一个推荐杂志,可是那个杂志非SCI,我应该怎么给之前的编辑回稿件呢~急求~

Thank you very much for the opportunity to consider your manuscript "Ameliorative effects of a promising AChE inhibitor nootkatone on impaired learning behavior in Aβ1-42-injecet mouse" for publication in Drugs & Aging.

We regret that we are unable to consider your paper for publication in this journal, as Drugs & Aging does not generally publish preclinical animal studies of this kind.  

However, the topic is of interest for our sister journal, Drugs in R & D, and we would like to recommend that this article be considered for publication in this journal.

Drugs in R & D is a Medline-indexed, peer-reviewed journal and accepts research on drugs in every stage of development. The journal is an 'open-access' journal, i.e. if accepted for publication, your paper will be freely available to readers all over the world from the journal home page on SpringerLink. As an open access journal, Drugs in R & D does not have paying subscribers and therefore manuscript processing and publishing charges are normally recouped via the Article Processing Charge (APC). However, as this is a recommended transfer from Drugs & Aging, the Editor would be prepared to waive the usual charge if you choose to transfer your submission.

As with all Adis manuscripts, your manuscript will be independently peer reviewed and edited by experts. Further information about this journal can be found at www.Springer.com/journal/40268.

We look forward to hearing from you shortly.

With kind regards,
回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐,对您同样有帮助:

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

史枭袅

铁虫 (初入文坛)

【答案】应助回帖

感谢参与,应助指数 +1
不用回复就行了,然后再找你想发表的期刊就行了。。。
努力了就好。。。。
2楼2014-03-21 13:36:44
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

makunjida

至尊木虫 (知名作家)

【答案】应助回帖

感谢参与,应助指数 +1
不需要回复的编辑只是套模板回复的

[ 发自手机版 http://muchong.com/3g ]
3楼2014-03-21 14:41:35
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

lb1527

金虫 (小有名气)

引用回帖:
2楼: Originally posted by 史枭袅 at 2014-03-21 13:36:44
不用回复就行了,然后再找你想发表的期刊就行了。。。

可是现在我文章的状态是Submission Transferred 不是reject。可是转投吗
4楼2014-03-21 14:51:05
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

huicun

木虫 (著名写手)

【答案】应助回帖

感谢参与,应助指数 +1
转投吧,编辑已经拒了,邮件就是证明。
登高望远!
5楼2014-03-21 16:14:43
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

ws861227

铁虫 (著名写手)

【答案】应助回帖

感谢参与,应助指数 +1
找别的期刊吧,不用回复的
6楼2014-03-21 17:31:46
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

gaojunhn

木虫 (正式写手)

【答案】应助回帖

★ ★ ★
感谢参与,应助指数 +1
lb1527: 金币+3, 有帮助 2014-03-22 12:55:31
回信说你不想投啊  这种情况必须要回啊  楼上都是没看清邮件就乱答    人家明明说了 We look forward to hearing from you shortly.
而且你的稿件状态也不是拒稿  这种情况投其他杂志不就是一稿多投吗?
提供scifinder 、reaxys 、全库及thomson pharma
7楼2014-03-21 19:08:32
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

wangjun890

至尊木虫 (知名作家)

【答案】应助回帖

感谢参与,应助指数 +1
不要你的稿,何必还要理他。
相投那就投那,与他没有任何关系。
努力,改投就是了。
8楼2014-03-21 19:30:56
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 lb1527 的主题更新
信息提示
请填处理意见